CDK9 and mantle cell lymphoma: Similar to the cell lines, CDK9 inhibition synergistically enhanced venetoclax‐induced apoptosis in all primary samples (Figure 3A), with CI values < 1 for all combinations except those of case 6 (a blastoid MCL) in which only a subset of combination doses displayed synergy (Figure S2).